Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PF-00489791 in Diabetic Nephropathy
NCT01200394Phase 2Completed
- Sponsor
- Pfizer
- Start
- Dec 2010
- Primary completion
- Jul 2013
- Modality
- Small Molecules
- Countries
- 15
01
Overview
A Phase 2 trial of PF-00489791 in diabetic nephropathy (DN), sponsored by Pfizer. Started Dec 2010; status: completed.
02
Drugs
PF-00489791
03
Conditions
diabetic nephropathy (DN)
Beyond the preview
Go deeper on NCT01200394.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01200394.